title: Endoplasmic reticulum protein ERp46 in renal cell carcinoma.
abstract: An established inverse clinical correlation between serum adiponectin levels and renal cell carcinoma (RCC) aggressiveness exists. We have recently demonstrated that adiponectin suppresses clear cell RCC (ccRCC) progression through interaction with its receptor, adiponectin receptor 1 (AdipoR1). ERp46 has been shown to inhibit adiponectin signaling via interaction with AdipoR1 in HeLa cells. However, the expression of ERp46 in RCC has not been described thus far. The objectives of this study were to investigate ERp46 in RCC, its expression, its effects on RCC growth in a mouse model and whether it interacts with AdipoR1. We demonstrated a higher ERp46/AdipoR1 expression ratio in metastatic compared to non-metastatic ccRCC, as determined by immunohistochemistry of tissue microarrays and subsequent image analysis. When ERp46 was stably knocked down using shRNA or overexpressed in murine RCC RAG cells, RCC growth after subcutaneous injection in BALB/c nude mice was inhibited and accelerated, respectively. In vitro analysis to determine the molecular interaction between AdipoR1 and ERp46 included co-immunoprecipitation using human ccRCC 786-O cells and a bacterial adenylate cyclase-based two hybrid system and demonstrated no sustained AdipoR1-ERp46 interaction. This is the first report to suggest a role for ERp46 as a potential therapeutic target in RCC given its expression profile in human RCC samples and its effect on in vivo RCC growth. Since a stable interaction with AdipoR1 could not be established, we suggest that the tumorigenic properties of ERp46 in RCC cells are not related to an inhibitory modulation of AdipoR1.
authors.affiliation: Department of Surgery, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
authors.forename: Wilhelmina C M
authors.initials: WC
authors.lastname: Duivenvoorden
authors.affiliation: Department of Surgery, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
authors.forename: Athanasios
authors.initials: A
authors.lastname: Paschos
authors.affiliation: Department of Surgery, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
authors.forename: Sarah N
authors.initials: SN
authors.lastname: Hopmans
authors.affiliation: Department of Surgery, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
authors.forename: Richard C
authors.initials: RC
authors.lastname: Austin
authors.affiliation: Department of Surgery, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
authors.forename: Jehonathan H
authors.initials: JH
authors.lastname: Pinthus
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002292:Carcinoma, Renal Cell / Q000378:metabolism* / Q000473:pathology; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D019704:Protein Disulfide-Isomerases / Q000378:metabolism*
chemical_list: D019704:Protein Disulfide-Isomerases; C480743:TXNDC5 protein, human